Thu, April 2, 2009
Wed, April 1, 2009
Tue, March 31, 2009
Mon, March 30, 2009
Fri, March 27, 2009
Thu, March 26, 2009
Wed, March 25, 2009
Tue, March 24, 2009
Mon, March 23, 2009
Fri, March 20, 2009
Thu, March 19, 2009
Wed, March 18, 2009
Tue, March 17, 2009
Mon, March 16, 2009
Fri, March 13, 2009
Thu, March 12, 2009
Wed, March 11, 2009
Tue, March 10, 2009
Mon, March 9, 2009
Fri, March 6, 2009
Thu, March 5, 2009
Wed, March 4, 2009
Tue, March 3, 2009
Mon, March 2, 2009
Fri, February 27, 2009
Thu, February 26, 2009
Wed, February 25, 2009
Tue, February 24, 2009
Mon, February 23, 2009
Fri, February 20, 2009
Thu, February 19, 2009
Wed, February 18, 2009
Tue, February 17, 2009
Mon, February 16, 2009
Fri, February 13, 2009
Thu, February 12, 2009
Wed, February 11, 2009
Tue, February 10, 2009
[ Tue, Feb 10th 2009 ]: Market Wire
Cybex Announces 2008 Results

CryoPort, Inc.: CryoPort, Inc. Investors Agree to Restructure Corporate Debt


  Copy link into your clipboard //house-home.news-articles.net/content/2009/02/2 .. vestors-agree-to-restructure-corporate-debt.html
  Print publication without navigation Published in House and Home on , Last Modified on 2009-02-25 14:37:07 by Market Wire
          🞛 This publication is a summary or evaluation of another publication

LAKE FOREST, CA--(Marketwire - February 25, 2009) - CryoPort, Inc. (OTCBB: [ CYRX ]), a leading developer of frozen shipping technologies, today announced that it has successfully renegotiated the terms of its Secured Convertible Debenture. The terms of this agreement will be more fully disclosed in the Company's Form 8-K that will be filed with the Securities and Exchange Commission.

CryoPort CEO Larry Stambaugh stated, "We are pleased to have our investors show their continued confidence in our Company's future. While CryoPort is not immune from the challenges posed by the historic economic situation, we look forward to continued and expanded execution upon our vision."

About CryoPort, Inc.

CryoPort ([ www.cryoport.com ]) develops leading edge, proprietary, technology-driven frozen shipping products for use in the rapidly growing global biotechnology and biopharmaceutical cold shipping chain. The products developed by CryoPort are essential components of the infrastructure required for the testing, research and end user delivery of temperature-sensitive medicines and biomaterials in an increasingly complex logistical environment.

"SAFE HARBOR"

This press release contains forward-looking statements. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.


Publication Contributing Sources

Similar House and Home Publications